A carregar...

Regulatory review time and post-market safety events for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study

AIMS: Regulatory review time has been associated with post-market medication safety issues in the United States. Our objective was to evaluate whether regulatory review time and near deadline approval are associated with post-market safety events (PMSEs) for novel medicines approved by the European...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Clin Pharmacol
Main Authors: Zeitoun, Jean-David, Lefèvre, Jérémie H, Downing, Nicholas S, Bergeron, Henri, Ross, Joseph S
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4594708/
https://ncbi.nlm.nih.gov/pubmed/25808713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12643
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!